Aktuellt
SENASTE
The Breakthrough Device Designation (BDD) is a timely stepping stone for XVIVO and the Liver Assist solution. This status signals that the process toward a US launch is more robust. We can expect further information on XVIVO’s yearly CMD tomorrow afternoon.
LÄS MER
